Mirae Asset Global Etfs Holdings Ltd. Edgewise Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 29,286 shares of EWTX stock, worth $558,484. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,286Holding current value
$558,484% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EWTX
# of Institutions
144Shares Held
96.7MCall Options Held
45.7KPut Options Held
5.3K-
Orbimed Advisors LLC San Diego, CA15MShares$286 Million6.52% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$170 Million2.42% of portfolio
-
Novo Holdings Hellerup, G76.34MShares$121 Million8.16% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$115 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$111 Million1.4% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.2B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...